The Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy…
WASHINGTON, DC – The Natural Products Association (NPA) today renewed its position that the Food and Drug Administration (FDA) must take immediate and substantive action to regulate CBD products, including establishing a safe level of daily consumption and establishing a…
Companies producing and selling hemp-derived CBD products would have access to essential banking services under new legislation introduced today in the New Jersey State Senate. The legislation, introduced by State Senator Robert W. Singer (R-NJ-30), would clarify that banks…
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.